Clinical Trials Logo

Postural Tachycardia Syndrome clinical trials

View clinical trials related to Postural Tachycardia Syndrome.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT03218761 Enrolling by invitation - Clinical trials for Postural Tachycardia Syndrome

POTS NET mRNA Functional Correlation With NET Activity

Start date: July 14, 2017
Phase:
Study type: Observational [Patient Registry]

DNA Acetylation can be responsible for significant down-regulation of transcription of the Norepinephrine Transporter (NET). NET is an important clearance transporter that removes norepinephrine (NE) from sympathetic neuronal synapses. Very low levels of NET can "cause" Postural Tachycardia Syndrome (POTS) or make these patients more susceptible to certain medications. Quantified NET messenger RNA (mRNA) levels from a peripheral blood sample may be able to assess NET availability, which is simpler than older methods. This has not been validated against NET function. In this protocol, the investigators seek to assess whether these NET mRNA levels correlate with NET function. The investigators will assess the DHPG (NET dependent NE metabolite):NE ratio in POTS patients and control subjects from both plasma and urine samples.

NCT ID: NCT02725060 Enrolling by invitation - Clinical trials for Cardiovascular Diseases

Autoimmune Basis for Postural Tachycardia Syndrome

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to see if some people with postural tachycardia syndrome (POTS) have higher levels of immune proteins (autoantibodies) directed against receptors of the autonomic nervous system, and if these autoantibodies make a difference in their POTS symptoms. The investigators also want to see if the levels of these autoantibodies stay the same over time.

NCT ID: NCT01761825 Enrolling by invitation - Clinical trials for Postural Tachycardia Syndrome

The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome

Start date: December 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Ivabradine is an effective treatment for postural tachycardia syndrome.